Dog Cloning- Market Scope
Cloned dog means a genetic twin of any dog that shares many characteristics of the current dog including appearance, intelligence, and temperament. Increasing dog death rates due to accidents and critical diseases like cancer have created significant opportunities for the market. Further, increasing research such as the long-term health and lifespan of cloned dogs is likely to fuel growth and increase the production of transgenic dogs.
|Unit||Value (USD Million)|
|Key Companies Profiled||ViaGen, Inc. (United States), Sooam Biotech (South Korea), Sinogene Pet Cloning (China), BoyaLife (China) and My Friend Again|
The global market is niche and consists of a few players who are competing with each other. Increasing research and changing consumer behavior are likely to create significant opportunities for the market. Further, an increasing number of players is expected to enter in the market and is anticipated to enhance competition and growth of the dog cloning market.
ViaGen, Inc. (United States), Sooam Biotech (South Korea), Sinogene Pet Cloning (China), BoyaLife (China) and My Friend Again are some of the key players that are part of study coverage.
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
The study have segmented the market of Global Dog Cloning- market by Type , by Application (Companion Dogs, Service Dogs and Others) and Region with country level break-up.
On the basis of geography, the market of Dog Cloning- has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.
In February 2021, US scientists successfully cloned an endangered animal, the black-footed ferret from the frozen cell of an ancestor that died over 30 years ago. According to U.S. Fish and Wildlife Service, the black-footed ferret is North America's rarest land animal that is native to the Great Plains.
Dog Cloning- Market Dynamics:
|Trends Influencing Market|
- Increasing Importance of Dog Cloning and Production of Transgenic Dogs for Research Purposes
- Increasing Focus on the Research & Development Technological Advancements for Cloning of Dogs
- Requirement of High Costs for Cloning Procedures Can Create Hurdles for the Market
- Early Deaths in Cloned Dogs as Compared to Regular Dogs May Slow Down Market Growth
- Growing Adoption of Dog as a Pet in Countries like the United States and China
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Dog Cloning Service Providers, Venture Capitalists and Private Equity Firms, Regulatory Bodies, Research Organizations and Others